EcoDrugPlus

Ribosomal Protein S9

Ensembl ID : ENSPREG00000007924
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSPREG00000000647
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSPREG00000011579
Gene Symbol: RPLP1
3 Cross references
377 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf

Ensembl ID : ENSPREG00000013979
Gene Symbol: LOC103469576
3 Cross references
191 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSPREG00000001033
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSPREG00000019487
Gene Symbol: LOC103478630
2 Cross references
381 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSPREG00000009108
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:

Si:dkey-91m11.5

Ensembl ID : ENSPREG00000016304
Gene Symbol: SI:DKEY-91M11.5
1 Cross references
131 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSPREG00000004834
Gene Symbol: SIGMAR1
3 Cross references
204 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSPREG00000002824
Gene Symbol: SIRT1
3 Cross references
156 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSPREG00000004106
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Protein Type 4 Subunit Alpha B-Like

Ensembl ID : ENSPREG00000021599
Gene Symbol: LOC103478857
3 Cross references
248 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).